Human adenoviruses (HAdVs, short Ad) replicate and assemble particles in the nucleus.
Introduction
DNA-viruses and retroviruses maintain and replicate their genomes in host cell nuclei using histone-based nucleosomes, similar to chromatin, or they encode their own DNAbinding and organizing proteins (35, 46, 48) . They assemble and maintain their genomes in different chromatin states by packaging the nucleic acids into proteinaceous capsids and sometimes lipid envelopes, and thereby traffic their genome within and transmit it between cells (8, 42) . The SV40 polyomavirus, for example, packages its virion DNA with cellular core histones and uses histones to replicate in infected nuclei (20) .
Herpesviruses, on the other hand, condense their double-strand DNA in particles with the help of polyamines, and use histones during latent residence within infected nuclei, or use irregularly spaced nucleosomes during productive phases of infection (46) .
Adenoviruses replicate and assemble particles in the nucleus. They encode their own histone-like proteins to condense a linear double-strand DNA genome of about 36 kbp into a proteinaceous DNA-core. Although it is unknown how the viral DNA is precisely organised in the virion, isolated cores of species C human adenovirus serotypes 2 or 5 (HAdV2/5, short Ad2/5) contain six viral proteins, the basic proteins V, VII and X (pV, pVII, pX), the terminal protein covalently attached to the 5' ends of the DNA, and a small number of protein IVa2 and L3/p23 protease, which are involved in DNA encapsidation and transcriptional regulation, or virion processing (reviewed in 4, 49) . Proteins V, VII and X are tightly interconnected as indicated by chemical cross-linking experiments (12) .
Digestion of virion cores with staphylococcal nuclease combined with electron microscopy (EM) analyses and stoichiometric calculations suggested a model where the viral DNA is organised into approximately 180 nucleosome-like units by three subunits of dimeric pVII interspersed with one copy of pV (5, 11, 14, 41, 57, 64) . This model predicts 1080 copies of pVII and 180 copies of pV, which is 10-20% higher than the experimentally determined amounts of pVII and pV in isolated virion DNA (34, 63) , suggesting that there are stretches in the viral genome lacking pVII and pV. pV not only binds the viral DNA in a sequence independent manner, it also bridges the DNA-core and the capsid by interacting with pVI on the inner side of the major capsid protein hexon (12, 36, 37, 47, 51) . Interestingly, a pV-deleted Ad5 gave rise to low levels of viral particles, suggesting that pV was involved in the assembly of infectious virions (61) . Mutations in the gene encoding the precursor of pX could compensate for the lack of pV suggesting redundancy for core organisation by molecular adaptation. This is also supported by the notion that pV is specific for Mastadenoviruses, which exclusively infect mammals (http://www.vmri.hu/~harrach/ADENOSEQ.HTM).
Viral infections start with entry, which delivers subviral particles to the cytosol. Invariably, the condensed viral genomes have to be uncoated for infection to proceed (23) . The uncoating process of Ad2/5 starts at the plasma membrane, when virion fibers bind their primary receptor, the coxsackievirus Ad receptor CAR, and alpha v integrin coreceptors bind to penton base, which anchors fiber to the capsid (3, 8, 39, 67) . Ad2/5 release their fibers prior to or during endocytosis although the underlying mechanism is unknown (27, 43 ). An early step of Ad2/5 uncoating is sensitive to defensins, which bind virions and preclude viral escape from endosomes to the cytosol (45) , phenotypically mimicking the fate of the uncoating-impaired and escape-defective Ad2 mutant Ad2-ts1 (22, 31) . The cytosolic Ad2/5 capsids traffic on microtubules to the nuclear pore complex (NPC), where they bind to the CAN/Nup214 receptor, and release their genome into the nucleus (25) .
This process is sensitive to the macrolide antibiotic leptomycin B (LMB), which inhibits nuclear protein export and prevents the attachment of incoming virions to the nuclear pore complex (56) . The precise composition of the imported DNA is unknown (reviewed in 48) . It is known, however, that pVII remains with the incoming viral genome in the nucleus during the early infection phase (65, 68) . pVII together with pV then assembles newly synthesised viral DNA into core structures that are packaged into virions and released upon nuclear disintegration (reviewed in 4). Here we report the generation and initial characterization of a novel adenovirus, which expresses the GFP-pV fusion protein instead of pV under the endogenous viral promotor. This is the first small DNA-tumor virus with a fluorescent full length core.
Materials

Construction of Ad2-GFP-pV
Ad2_BAC53 is derived from Ad2 reference strain "adenoid 6" (31) . The Ad2-GFP-pV insertion mutant was obtained using exposon mutagenesis as described (50) (see Fig.   1 ). Briefly, in the first step a mini-Tn cassette (transprimer-1) was amplified from pGPS1.1 and inserted by ET recombination into BAC53 containing the full length wild type genome of Ad2 (31) . Synthetic oligonucleotide primers for insertion of transprimer-1 contained at their 5' end homologies to position 16491-16538 (upstream of pV) and 16539-16586 (downstream) relative to the adenoviral genome. The priming sequences for the transprimer-1 cassette of pGPS1.1 were as published (50) . Successful insertion of transprimer-1 was examined by restriction analysis and partial sequencing of the insertion sites. To replace the transprimer-1 element with eGFP coding sequences recombinant BAC-DNA was amplified from two independent clones and transprimer-1 sequences were excised in vitro using TnsABC (New England Biolabs) in the presence of the acceptor plasmid pST76T. The insertion fragment containing the ORF of eGFP was obtained as follows. The eGFP gene including a small linker portion was PCR amplified from pEGFP-C1 (Clontech). Priming regions were designed such that the fragment contained position 613-1380 of the plasmid. The 5' extensions contain the recognition site for SapI, one random base plus 3 bases identical to the upstream or downstream region of the insertion site. Primer sequences were as follows: upstream primer (5'-GTC AGC TCT TCC GCT ATG GTG AGC AAG GGC GAG-3'), downstream primer (5'-CAA GGC TCT TCT CAT GGT ACC GTC GAC TGC AGA ATT C-3'). The SapI excised insertion fragment was ligated into the TnsABC* linearised BAC and the recombinants were recovered by transformation into competent bacteria. Successful replacement of pV by GFP-pV was confirmed by restriction analysis and partial sequencing of the insertion sites. Four independent colonies were chosen and amplified for reconstitution of virus by calcium phosphate transfection of 80% confluent HER-911 cells in a 10 cm cell culture dish with 10 !g SnaBI linearised BAC DNA. 48 h post-transfection cells were split 1 to 4, and viruses harvested from cells and supernatant at onset of cytopathic effects (passage 1, p1), serially passaged in four 10 cm dishes of A549 cells (p2), and then in twenty 10 cm dishes (p3), followed by virus purification from cells. The supernatants were used for further amplification rounds until p7. Viruses (termed Ad2-GFP-pV) from passages lower than 8 had normal DNA patterns of restriction enzyme digests.
Cells, transfection and antibodies
HeLa-ATCC and human lung carcinoma A549 cells were purchased from American Type Culture Collection, Rockville, MD. Ad5-E1 transfected human embryonic retinoblast 911 cells (19) were obtained from Dr. S. Hemmi (University of Zurich, Switzerland). Cells were grown as monolayers in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (GIBCO-BRL) on alcian blue-coated glass coverslips (58) Guinea Pig anti-DBP (DNA Binding Protein) was from W. Deppert (University of Hamburg, Germany). Purified rabbit anti-pV C-term antibody was manufactured by immunising rabbits with the synthetic peptide RRVAREGGRTLVLPTAR, position 347-363 of Ad2 pV. Serum was harvested and an enriched IgG fraction was affinity purified on immobilised peptide (Davids Biotechnologie, Regensburg, Germany). All animal work was done in accordance with NIH standards for animal welfare under the animal welfare number A5646-01, and approved by the Animal Care and Use Committee, Office for Environment, Nature and Consumer Protection (Regensburg, Germany).
Amplification, purification and labeling of viruses
Ad2 and Ad2-GFP-pV were grown, isolated and labelled with Atto647 and Atto565 dyes (Atto-tec, Germany) as described (26, 44) .
Virus quantification
Virus titers were determined using either tissue culture infective dose 50 (TCID 50 ) or a modified fluorescent focus assay (FFA). In both assays virus was titrated on HER-911 cells plated on 96-well plates. In case of TCID 50 infection was allowed to proceed for 6 days while in the FFA cells were fixed after 4 days. For the calculation of fluorescent focus forming units per ml (fffu/ml) cells were fixed, quenched, immunostained for expression of protein V and fluorescent focus units counted using a fluorescence microscope. A fluorescent focus was defined as 3 or more adjacent cells expressing protein V or GFP-pV. FFA titers were calculated using the formula of Spearman and Kaerber (54) was collected in 2 ml tubes and frozen while cells were broken up in 1 ml medium by freeze-thaw 3 times, transferred to 2 ml tubes and supplemented with another ml of growth medium. Supernatants and cell lysates were centrifuged and viral titers determined on A549 cells.
Preparation of pyridine cores
To test if GFP-pV fractionated with the viral core, double CsCl gradient-purified Ad2-GFP-pV (or Ad2) virions were dialysed against 5 mM Tris pH 8.1, and 50 !g of each virus
supplemented with 16 !l pyridine to 8% (v/v), similar to a previously described protocol (17) . Samples were incubated at 37°C for 2 h, followed by centrifugation on a 10-30% sucrose gradient at 111000 x g, 4°C for 2 h. 14 160 ! l fractions were collected, TCA precipitated and dissolved in 20 ! l sample buffer. 
Thermostability assay
Accessibility of viral DNA from double CsCl gradient purified Ad2 or Ad2-GFP-pV for the DNA intercalating fluorescent dye TOTO-3 iodide (1 mM solution in DMSO, Invitrogen) with 642/660nm excitation/emission was measured after heat-shock treatment at different temperatures. Specifically, samples containing 5 !g virus diluted in buffer containing 10 mM Tris pH 8.1, 150 mM NaCl, 1 mM MgCl and 1 !M TOTO-3 in a total volume of 50 !l were prepared in 1.5 ml Eppendorf tubes on ice, heated at indicated temperatures in a heating block for 3 min and rapidely chilled on ice. The samples were transferred to a 96-well plate and fluorescence was measured at 642±8 nm excitation and 660 ± 9 nm emission with the Tecan SAFIRE II microplate reader. h) or non-infected HeLa-ATCC cells grown on cell culture dishes were fractionated by 12% SDS-PAGE, blotted and stained with affinity purified rabbit anti-pV antibody followed by goat anti-rabbit conjugated horse raddish peroxidase staining.
SDS-PAGE
Results
Genetic construction and reconstitution of Ad2-GFP-pV
We generated recombinant Ad2 genomic DNA with an N-terminally eGFP-tagged core protein V (GFP-pV) using exposon mutagenesis of Ad2_BAC53, yielding Ad2-GFP-pV (Fig. 1A, B) . The resulting bacterial artificial chromosome (BAC) DNA had the expected in silico predicted restriction fragments and correct sequence between GFP and pV ( Fig.   1C , not shown). Linearised BAC_Ad2-GFP-pV DNA was transfected into HER-911 cells, and infectious particles were serially expanded in A549 cells through about 5 passages, and purified by double CsCl density gradient as described (27) . XhoI restriction enzyme digests of DNA from these particles yielded the expected fragments (Fig. 1B) . This suggested that Ad2-GFP-pV was stable for at least 5 passages. At passages higher than 10, loss of GFP-pV expression by Ad2-GFP-pV was, however, observed and this coincided with genetic alterations in the pV locus (not shown).
Ad2-GFP-pV particles contain GFP-pV and are infectious
We next analysed the protein composition of CsCl-gradient purified Ad2-GFP-pV. SDS-PAGE and Coomassie blue analyses indicated that Ad2-GFP-pV had a protein band of about 75 kDa, which was absent in Ad2, and lacked a prominent band at about 48 kDa ( Fig. 2A) . Both of these bands were immunostained by an anti-pV antibody in Western blots, but only the 75 kDa band of Ad2-GFP-pV also reacted with an anti-GFP antibody (Fig. 2B ). This corresponded well with the calculated mass for this fusion protein, which is 70.303 kDa (Fig. 2C) . The other major structural proteins of Ad2-GFP-pV and Ad2
were normal in SDS-PAGE ( Fig. 2A) . The relative abundance of the viral structural proteins was estimated by densitometry using Coomassie blue stained protein II (hexon, pI = 5.1) as an internal reference and bovine serum albumin (BSA, pI = 5.8, http://expasy.org/tools/) as a calibration standard (Fig. 2C, D per virion, which is about 25% of the pV levels in Ad2. Importantly, both GFP-pV and Ad2 pV segregated with the viral DNA core in pyridine-disrupted virions fractionated in sucrose density gradients, although we noticed some proteolysis in both of the pelleted core fractions (Fig. 2E, F ).
Since pV links the viral DNA to the inside wall of the capsid (37), we determined the thermostability of Ad2-GFP-V particles by spectrofluorometric measurements of the binding of the DNA-interchalating dye TOTO-3 to isolated virions (Fig. 2G ). TOTO-3
binding to both Ad2-GFP-pV and Ad2 was constant in the range of 25° to 47°C, and sharply increased from 47 to 51°C where it reached a plateau at about 60°C. However, about 10-15% of the Ad2-GFP-pV particles bound the dye at 25°C, indicative of defective particles in the preparation, which could in part explain that 15-20% of the Ad2-GFP-pV particles bound to cells but did not endocytose (see Fig. 4A ).
Ad2-GFP-pV enters cells but is attenuated at particle production
To track the incoming GFP-pV, we isolated Ad2-GFP-pV particles and labeled the capsids with the fluorophore Atto647 according to previously established protocols (58).
The Atto647 dye was found to be specifically incorporated into the major capid protein hexon, as indicated by fluorography of SDS-PAGE fractionated virions (Fig. 3A) . Purified
Ad2-GFP-pV virions labeled with red Atto fluorophores retained their full infectivity compared to the non-labeled virions (not shown). Both, Atto-647-Ad2-GFP-pV and Ad2
were monodisperse as shown by negative-stain EM (Fig. 3B) . Dual color fluorescence microscopy indicated that most of the Atto-647-Ad2-GFP-pV particles were positive for both colors (Fig. 3C, arrows) with Gaussian distributions for both colors, indicating the presence of a single species of dual-colored particles (Fig. 3D) . Non-labeled Ad2 or Ad2-GFP-pV gave no signals in the red and green, or red channels, respectively, indicating specificity of detection (data not shown). Importantly, the Atto-647-Ad2-GFP-pV particles were stable in PBS at 37°C up to 150 min, indicating that these particles were suitable for analyses of entry into cells (Fig. 3E, F) . Interestingly, Atto-647-Ad2-GFP-pV particles lost about 50% of GFP-pV upon short incubation at 53°C, which was, however, not due to thermal GFP denaturation as shown before (1) . The loss of GFP-pV correlated with a sharp increase in DNA accessibility at 51°C, and represented rupture of particles (Fig.   2G ).
Entry of Ad2-GFP-pV particles into HeLa-ATCC cells was analysed by transmission EM.
Viral particle counts at the plasma membrane, endosomes and the cytosol indicated that Ad2-GFP-pV endocytosis occurred with similar kinetics as wild type Ad2, although 15-20% of the Ad2-GFP-pV particles were not endocytosis-competent (Fig. 4A) . At 90 min pi, about 50% of the Ad2-GFP-pV particles were in the cytosol, 30% in endosomes and 20% at the plasma membrane. Endosomal escape of Ad2-GFP-pV was confirmed by fluid phase marker dextran-FITC (10 kDa) uptake showing that Ad2-GFP-pV infection not only triggered dextran uptake but also release to the cytosol and the nucleoplasm, similar to Ad2 (data not shown, 38).
Ad2-GFP-pV was delayed at expressing the immediate early transactivator E1A compared to Ad2 (Fig. 4B) . This was more pronounced at 12 h than 20 h pi, suggesting that Ad2-GFP-pV could compensate a defect with time, consistent with the notion that Ad2-GFP-pV had a lower infectious particle to particle ratio than Ad2. In lung epithelial A549 cells, Ad2-GFP-pV gave 10 to 100-fold lower yields of cell-associated infectious particles compared to Ad2, although the amounts of cell-free infectious units were similar to Ad2 at 72 h pi (Fig. 4C) . These results were confirmed by measurements of tissue culture infectious dose 50 (TCID50) and fluorescent focus forming units (fffu) (Fig. 4D) .
We speculate that Ad2-GFP-pV is slightly impaired at particle assembly. Importantly, both newly synthesised GFP-pV and pV were found in similar subnuclear structures lacking the viral DNA binding protein (DBP) (Fig. 5A) , as indicated by an anti-pV polyclonal antibody (Fig. 5B, C) .
GFP-pV dissociates from Ad2-GFP-pV particles during entry
We next analysed entry of Ad2-GFP-pV and the major core protein pVII into cells by confocal microscopy in live and fixed cells. Spinning disc confocal microscopy indicated progressive attachment of dual-color Atto565-labeled Ad2-GFP-pV to the periphery of HER-911 cells (Fig. S1 , and Suppl. Mov. 1). The number and average intensity of the Atto647-labeled capsid (representing hexon, see Fig. 3A ) remained approximately constant from 0 until 240 min pi, indicating that incoming virions were neither degraded nor released from the cells, consistent with earlier findings (Fig. 5A , B, 26, 60).
In contrast to the Atto647 fluorescence of the main capsid protein hexon, the GFP-pV fluorescence of Atto647-labeled virions dropped in a two step process. A rapid loss to about 35% of the original value was seen at 30 min pi, and the remaining GFP-pV disappeared at a slower rate to almost background levels at 90 min pi (Fig. 6A-C, column 2). Individual GFP-pV puncta distinct from capsids were occasionally found at 30 min pi but not at 0 min pi, suggesting that GFP-pV separated or was degraded from capsids during cell-binding, endocytosis or escape from endosomes. The cytoplasmic GFP-pV puncta were not stained with an anti-pVII antibody (Fig. 6A ), although this antibody detected a small percentage of cell-bound Ad2-GFP-pV at 0 min pi (Fig. 6D) , suggesting that these surface-bound capsids, but not the intracellular GFP-pV puncta contained viral DNA. We speculate that the pVII-positive particles at 0 min pi (Fig. 6A ) belong to the 10-15% DNA-dye positive Ad2-GFP-pV particles detected in the virus inoculum (Fig. 2G) .
The pVII-positive particles were faintly positive for GFP-pV at 0 min but not 30 min pi, suggesting that GFP-pV disappeared from the broken particles (Fig. 6E ).
In addition, the average pVII fluorescence of the Atto647-capsid population steadily decreased from 0 to 240 min pi, suggesting that pVII is lost in a single phase (Fig. 6D) , in contrast to GFP-pV, which dissociates in two phases. Remarkably, the number of pVII-positive Atto647-capsids transiently increased to about 11% at 90 min and decreased again after 150 min pi (Fig. 6D ), consistent with ongoing nuclear import of viral genomes.
Many of the strongly pVII-positive puncta at the late time points (90-240 min pi) were in the nuclear area, often lacking Atto-647 fluorescence (Fig. 6A, column 4) , suggesting that these pVII puncta represented uncoated genomes (24) . Since incoming pVII but not capsids are delivered into the nucleus 1 to 3 h pi (24, 56, 68) , and pVII is released from the viral DNA in the nucleus by ongoing transcription (13), our data suggest that the nuclear pVII puncta represent infectious incoming genomes, in agreement with recent analyses (65) . Remarkably, we did not find GFP-pV on pVII-positive puncta in the nucleus, suggesting that it was lost prior to or during nuclear import of the viral genome.
The second step of GFP-pV dissociation is revealed by treatment of cells with leptomycin B
We noticed that the loss of GFP-pV from capsids correlated with increased capsid staining by the polyclonal anti-hexon antibody R70 from 0 to 150 min pi as indicated by confocal microscopy, and quantifications of R70-positive particles (Fig. 7A, B, E) . The R70-positive particles had significantly lower amounts of GFP-pV than the R70-negative particles (Fig. 7C) , while the overall number of particles remained fairly constant (Fig.   7D ), indicating that loss of GFP-pV correlated with increased R70 epitopes. R70
preferentially labels the hexon protein of disassembled virus particles (60) . This was confirmed by Western blotting, where R70 reacted with newly synthesized SDSdenatured monomeric hexon, and monomeric and aggregated hexon from Ad2 and Ad5 particles (Fig. 8A) . By immunofluorescence analyses, R70 recognized hexon from Ad2 infected control HeLa cells but not Ad2-infected cells treated with the nuclear export inhibitor leptomycin B (LMB) (see Fig. 8B,) . LMB confines the incoming Ad2/5 particles to the cytoplasm of HeLa cells or blocks them at the microtubule-organizing center in other cell types, such as human embryonic retinoblast (HER) 911 cells, and prevents Ad2/5 attachment to the nuclear pore complex, and nuclear import of pVII (Fig. 8B, 56 ).
This suggested that R70 epitopes, and hence the second step of GFP-pV dissociation depend on virus contact with the nuclear pore complex, which is the site where capsids disassemble and release the DNA (60).
This notion was confirmed by confocal microscopy of LMB-treated HER-911 cells infected with Atto647 labeled Ad2-GFP-pV (Fig. 9) . As expected, the particles readily enriched at a perinuclear spot, which was identified as the MTOC by gamma-tubulin staining (not shown, 56), from 15 min up to 150 min pi. These perinuclear viruses were strongly positive for GFP-pV, but did not contain R70 epitopes, indicating that they were not disassembled but contained DNA-cores. Likewise, LMB treatment of HeLa cells blocked the dissociation of GFP-pV as indicated by ratiometric analyses of GFP-pV / Atto647 fluorescence in image stacks (Fig. 10) . These images were recorded by automated fluorescence microscopy at constant illumination and with chromatic aberrations corrections (Fig. S2) . The ratiometric analyses showed that GFP-pV / Atto647 was 0.105 at 30 min pi, and dropped to 0.085 at 150 min pi, close to background levels ( Fig. 10A , B, and not shown). At 0 min pi it was approximately 0.2, which closely matched the ratio of GFP-pV / Atto647 determined by single slice confocal microscopy (see Fig. 6C , insert). The GFP-pV / Atto647 ratios at 150 min pi but not 30 min pi were largely and significantly increased by LMB (Fig. 10B) , showing that the second step of GFP-pV loss is affected by LMB. LMB blocks virus attachment at the nuclear pore complex (56) , which suggests that the second step of GFP-pV loss requires virus contact with the nuclear pore complex. This notion was corroborated by the detection of Atto647-Ad2-GFP-pV particles in single slice confocal micrographs in close proximity of POM121-mCherry-labeled nuclear pore complexes (16) (Fig. 11, white arrows) . Together, these results show that the early detachment of GFP-pV occurs before or shortly after virus penetration into the cytosol, while the second step takes place at the nuclear membrane, presumably the nuclear pore complex. The Ad2-GFP-pV is hence a novel tool to analyse distinct steps of capsid uncoating.
Discussion
Imaging the subcellular localizations of viral DNA, RNA, proteins or particles at high resolution has greatly advanced concepts in molecular virology and cell biology. It has been significantly enhanced by labeling of viruses with chemical fluorophores or fluorescent proteins (reviewed in, 6, 8, 25) . For adenoviruses, GFP had been fused to the capsid-stabilizing protein pIX (240 copies per virion, 52), and purified virions were observed at the plasma membrane and the cytoplasm (40) . In addition, an adenovirus encoding pV-GFP, pre-pVII-GFP and a dual color Ad5 with pIX-RFP and pV-GFP were also reported (33, 62) . The utility of these viruses was, however, limited. Both pre-pVII-GFP and pV-GFP were expressed from an artifical promotor in the deleted E3 region of the genome, while endogenous pre-pVII and pV were also expressed, which resulted in low incorporation of pV-GFP in virus particles (62) . In addition, the pV-GFP expressing Ad5 stocks contained significant amounts of disrupted virions (33) . The pIX-RFP / pV-GFP labeled virions on the other hand were heterogeneous with respect to green and red fluorescence, and it remained unknown how these viruses enter or exit cells.
Our detailed entry studies here revealed two new phases of virus uncoating. The first phase was the loss of a large fraction of GFP-pV from the particles at 30 min pi, when the majority of endocytosis-competent Ad2-GFP-pV has arrived in the cytosol (Fig. 6C) . We suggest that this early loss of GFP-pV coincides with structural changes of the capsid, such as the loss of fibers and pentons, or capsid-stabilizing proteins IIIa and VIII (18, 27, 43, 51) . We assume that these disassembly steps occur in most of the entry-competent Ad2-GFP-pV, as shown for Ad2 before (27) . Biochemical experiments and crosslinking studies have suggested that pV attaches the viral DNA to the capsid possibly via pVI (12, 37) . pVI has recently been assigned to hexon cavities inside the capsid (47, 53) , but precisely how the 360 copies of pVI are arranged within the capsid is unknown.
Intriguingly, unassigned structures around the 5-fold symmetry of the vertices projecting towards the DNA-core have been detected in cryo-EM studies, and these structures have been tentatively assigned to pVI (18, 55) . Since dimers of pVI bind pV in biochemical assays, it is possible that pV acts as a DNA-organizer near the vertices. pV could be released when penton base or fibers detach from the capsid, either together or separately from pVI and penton base.
The second novel phase for adenovirus uncoating identified here was that about 30% of GFP-pV dissociates from the cytoplasmic particles in the absence of LMB, because LMB blocked the release of 30% of the GFP-pV from cytoplasmic particles (Fig. 6) . LMB blocks the attachment of incoming Ad2/5 to the nuclear pore complex and inhibits capsid disintegration (56), consistent with a key role of the nuclear pore complex in the final step of capsid disassembly (60) . This suggests that, in addition to linking the viral DNA to the capsid, pV functions in core assembly and organisation, in close contact with the virion DNA, as supported by UV-crosslinking and fractionation studies (7, 10, 17) .
Remarkably, the nucleus did not contain GFP-pV (Fig. 6) , as reported for wild type pV (30, 33) . The absence of pV or GFP-pV on the viral cores in the nucleus is not surprising, since earlier studies showed that the viral DNA and pVII alone can be a template for replication and transcription without pV (9, 29, 68) . Possibly, posttranslational modifications of the viral core proteins pV and pVII, such as ADPribosylation, phosphorylation or acetylation facilitate a relaxation of the core, and thereby aid the detachment of DNA from the capsid (15, 21, 66) .
In summary, Ad2-GFP-pV is the first fluorescent DNA-core labeled small DNA tumor virus carrying a full length genome. It has an estimated number of 38 GFP-pV copies per virion compared to 157-170 copies of pV in wild type Ad2 (34, 63) , and Ad2-GFP-pV is monodisperse. This allows to use Ad2-GFP-pV as a point source of defined fluorescence for quantitative analyses of GFP in live cell microscopy experiments. Ad2-GFP-pV is also a novel tool to measure viral DNA uncoating, and in future experiments can provide insights into viral spreading dynamics within organisms in disease and therapy.
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Figure Legends
Note the clustering of GFP-pV positive particles at a distinct perinuclear site, the MTOC (white arrows), identified by anti-gamma-tubulin staining (not shown). HER-911 cells were transfected with a POM121-mCherry expressing plasmid using FuGENE 6 (Roche) according to the manufacturer's instructions. Cells were serum starved overnight and warm infected with 0.2 !g /ml Atto647-Ad2-GFP-pV for 15 min, medium removed and incubated for another 45 min at 37°C 5% CO 2 . Cells were recorded with the spinning disc confocal microscope without beamsplitter.
Fluorescence crosstalk control experiments
Ad2, Ad2-GFP-pV, Atto565-Ad2 or Atto565-Ad2-GFP-pV were attached to coverslips, mounted with DAKO and recorded by spinning disc confocal fluorescence microscopy in beamsplitter mode (GFP and Atto565) using identical illumination settings. Ad2, Atto647-Ad2, Ad2-GFP-pV or Atto647-Ad2-GFP-pV were adsorbed to the bottom of 96-well clear bottom plates at 20°C for 15 min. Wells were washed with PBS, medium removed and 100 !l fresh PBS was added. Virus particles were recorded with the MetaXpress-Micro automated microscope focusing on the bottom of the plate using identical illumination settings (GFP and Atto647) for all viruses.
Image processing, particle scoring and quantification of GFP-pV in Ad2 particles
Images were recorded with an automated ImageXpress MICRO A Matlab based algorithm was used for particle scoring. In brief, Otsu's method (1) was used for thresholding of maximum intensity projections generated from background and aberration corrected images acquired in the Atto647 channel. A manually set area threshold was used to attribute contiguous pixel over the grey threshold to virus particles in an image mask. Particles that met the area threshold were displayed in green whereas particles that did not fulfil the threshold criteria were depicted in red ( Figure   S6C ). This image mask was subsequently employed to measure average fluorescent intensities over the particle areas in both average intensity projections from GFP channel images and Atto565 channel images. The following particle parameters were extracted and used for analysis: Particle size, average GFP fluorescence intensity, average Atto565 fluorescence intensity, and the ratio (GFP/Atto647) of the two aforementioned intensities. Statistical analysis was performed with Microsoft Office Excel. The source code of all Matlab routines is available from the authors upon request. 
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